Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Relapsed Marginal Zone B-Cell Lymphoma: Clinical Features and Treatment Outcome.

Blood (2009) 114 (22): 5017.

https://doi.org/10.1182/blood.V114.22.5017.5017

Published: 2009

Journal Articles

Clinical Significance of Autoantibody Expression in Allogeneic Stem Cell Recipients.

Joon Ho Moon, Soo Jung Lee, Jong Gwang Kim, Yee Soo Chae, Shi Nae Kim, Yun Jeong Kim, Young Rok, DO, Jang Soo Suh, Kun Soo Lee, Sang Kyun Sohn

Blood (2008) 112 (11): 2205.

https://doi.org/10.1182/blood.V112.11.2205.2205

Published: 2008

Journal Articles

Comparing Standard IPI with Revised-IPI in Patients with Diffuse Large B-Cell Lymphoma: Which Has a More Differential Potential for Predicting the Outcomes after R-CHOP Chemotherapy.

Deok-Hwan Yang, Jae Sook Ahn, Yeo-Kyeoung Kim, Je-Jung Lee, Young Jin Choi, Ho Jin Shin, Joo-Seop Chung, Joon Ho Moon, Yee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, Hyeoung-Joon Kim

Blood (2008) 112 (11): 2003.

https://doi.org/10.1182/blood.V112.11.2003.2003

Published: 2008

Journal Articles

Clinical Efficacy of VEL-CTD (Bortezomib, Cyclophosphamide, Thalidomide, and Dexamethasone) Regimen in Patients with Relapsed or Refractory Multiple Myeloma: A Phase II Study

Yeo-Kyeoung Kim, Je-Jung Lee, Sang-Kyun Sohn, Ho-Jin Shin, Joo-Seop Chung, Young-Jin Choi, Joon-Ho Moon, Yee-Soo Chae, Jong-Gwang Kim, Jae-Sook Ahn, Deok-Hwan Yang, Hyeoung-Joon Kim, the Korean Multiple Myeloma Working Party (KMMWP)

Blood (2008) 112 (11): 3693.

https://doi.org/10.1182/blood.V112.11.3693.3693

Published: 2008

Journal Articles

Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.

Yee Soo Chae, MD, Sang Kyun Sohn, MD, PhD, Jong Gwang Kim, MD, PhD, Yoon Young Cho, MD, Joon Ho Moon, MD, Byung Min Ahn, MD, Shi Nae Kim, MD

Blood (2007) 110 (11): 4258.

https://doi.org/10.1182/blood.V110.11.4258.4258

Published: 2007

Journal Articles

The Mobilization Effects of G-CSF, GM-CSF and Darbepoetin-α for Allogeneic Peripheral Blood Stem Cell Transplantation.

Shi Nae Kim, MD, Sang Kyun Sohn, M.D., Jong Gwang Kim, M.D., Yee Soo Kim, M.D., Yoon Young Cho, M.D., Joon Ho Moon, M.D., Byung Min Ahn, M.D., Soo Jung Lee, M.D., Yun Jeong Kim, M.D.

Blood (2007) 110 (11): 4932.

https://doi.org/10.1182/blood.V110.11.4932.4932

Published: 2007

Journal Articles

Early Onset of Acute Graft-Versus-Host Disease Indicating a Worse Prognosis in Terms of Chronic Graft-Versus-Host Disease and Survival Compared to Late Onset.

Sang Kyun Sohn, MD, Joon Ho Moon, M.D., Jong Gwang Kim, M.D., Yee Soo Chae, M.D., Yoon Young Cho, M.D., Byung Min Ahn, M.D., Shi Nae Kim, M.D., Soo Jung Lee, M.D., Yun Jeong Kim, M.D.

Blood (2007) 110 (11): 4979.

https://doi.org/10.1182/blood.V110.11.4979.4979

Published: 2007

Journal Articles

Risk Factors for Predicting CMV Infection in Allogeneic-PBSCT Setting: MNC Dose, Campath Use, and Acute GVHD Grade ≥II.

Byung Min Ahn, MD, Joon Ho Moon, M.D., Yoon Young Cho, M.D., Yee Soo Chae, M.D., Jong Gwang Kim, M.D., Sang Kyun Sohn, M.D.

Blood (2006) 108 (11): 5298.

https://doi.org/10.1182/blood.V108.11.5298.5298

Published: 2006

Journal Articles

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Byeong-Bae Park, MD, Jong Gwang Kim, MD,PhD, HyeonSeok Eom, MD,PhD, Hyo Jin Kim, MD,PhD, Hyuck Chan Kwon, MD,PhD, Sung Yong Oh, MD, Jung Hun Kang, MD, Suk Joong Oh, MD,PhD, Ho-Jin Shin, MD,PhD, Cheolwon Suh, MD,PhD, Jung Han Kim, MD, Ho Young Kim, MD, Sang Cheol Lee, MD, Kihyun Kim, MD,PhD, Chul W. Jung, MD,PhD, Won Seog Kim, MD,PhD

Blood (2006) 108 (11): 4670.

https://doi.org/10.1182/blood.V108.11.4670.4670

Published: 2006

Journal Articles

Treatment Outcomes for Imatinib Mesylate and Allogeneic Stem Cell Transplantation in Patients with CML Based on RQ-PCR, and the Efficacy of Dose Escalation of Imatinib Mesylate in Patients with Cytogenetic or Hematologic Resistance.

Sang Kyun Sohn, MD, Yoon Young Cho, MD, Byung Min Ahn, MD, Yee Soo Chae, MD, Jong Gwang Kim, MD, Joon Ho Moon, MD

Blood (2006) 108 (11): 4762.

https://doi.org/10.1182/blood.V108.11.4762.4762

Published: 2006

Journal Articles

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma

Dong Hwan Kim, Hee Du Jung, Jong Gwang Kim, Je-Jung Lee, Deok-Hwan Yang, Yeon Hee Park, Young Rok Do, Ho Jin Shin, Min Kyoung Kim, Myung Soo Hyun, Sang Kyun Sohn

Blood (2006) 108 (8): 2720–2725.

https://doi.org/10.1182/blood-2006-01-009480

Published: 2006

Includes: Supplemental data

Journal Articles

Multidrug Resistance-1 Gene Polymorphism Associated with the Outcomes after Allogeneic HLA-Identical Stem Cell Transplantation.

Dong Hwan Kim, MD, Seok Bong Jeon, MD, Jin Ho Baek, MD, Nan Young Lee, MD, Jong Gwang Kim, MD, Sang Kyun Sohn, MD, Jang Soo Suh, MD, Young Rok Do, MD, Ki Kyung Kwon, MD

Blood (2005) 106 (11): 1757.

https://doi.org/10.1182/blood.V106.11.1757.1757

Published: 2005

Journal Articles

Rapid Helper T-Cell Recovery at 3 Months Correlates to Successful Transplant Outcomes after Allogeneic Stem Cell Transplantation.

Joon Ho Moon, MD, Jin Ho Baek, MD, Dong Hwan Kim, MD, Sang Kyun Sohn, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Jang Soo Suh, MD

Blood (2005) 106 (11): 5201.

https://doi.org/10.1182/blood.V106.11.5201.5201

Published: 2005

Journal Articles

Time to First Acute Exacerbation Can Stratify the Patients According to Their Prognosis during Clinical Course of Chronic GVHD: Evaluation of New End-Point for Chronic GVHD.

Dong Hwan Kim, MD, Sang Kyun Sohn, MD, Kun Soo Lee, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Kyoo-Hyung Lee, MD, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD

Blood (2005) 106 (11): 5335.

https://doi.org/10.1182/blood.V106.11.5335.5335

Published: 2005

Journal Articles

Survival Benefit of Asymptomatic Cytomegalovirus Reactivation and Early Lymphocyte Recovery after HLA-Identical Allogeneic Peripheral Blood Stem Cell Transplantation.

Dong Hwan Kim, MD, Sang Kyun Sohn, MD, Jin Ho Baek, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Jae-Hoo Park, MD

Blood (2005) 106 (11): 5336.

https://doi.org/10.1182/blood.V106.11.5336.5336

Published: 2005

Journal Articles

Risk Factor Analysis for Predicting Chronic Graft-Versus-Host Disease of Progressive or Quiescent Type in a Cohort of Patients with a History of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Sang Kyun Sohn, MD, Dong Hwan Kim, MD, Jin Ho Baek, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Kyoo-Hyung Lee, MD, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD

Blood (2005) 106 (11): 5337.

https://doi.org/10.1182/blood.V106.11.5337.5337

Published: 2005

Journal Articles

Transplantation with Higher Dose of Natural Killer Cells Associated with Better Outcomes in Terms of Non-Relapse Mortality and Infectious Events after Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Matched Sibling Donors.

Sang Kyun Sohn, MD, Dong Hwan Kim, MD, Nan Young Lee, MD, Jin Ho Baek, MD, Jong Gwang Kim, MD, Jang Soo Suh, MD, Kun Soo Lee, MD, Kyu Bo Lee, MD, Ho Jin Shin, MD, Joo Seop Chung, MD

Blood (2004) 104 (11): 733.

https://doi.org/10.1182/blood.V104.11.733.733

Published: 2004

Journal Articles

IL-10 Promoter Gene Polymorphism Associated with the Occurrence of Chronic GVHD and Its Clinical Course during Systemic Immunosuppressive Treatment for Chronic GVHD after Allogeneic Peripheral Blood Stem Cell Transplantation.

Dong Hwan Kim, MD, Nan Young Lee, MD, Sang Kyun Sohn, MD, Jin Ho Baek, MD, Jong Gwang Kim, MD, Jung Lim Lee, MD, Jang Soo Suh, MD, Kun Soo Lee, MD, Kyu Bo Lee, MD

Blood (2004) 104 (11): 422.

https://doi.org/10.1182/blood.V104.11.422.422

Published: 2004

Journal Articles

Bcl-2 Mediated Apoptosis Interacts with p53-Dependent Pathway in Progression of Peripheral T-Cell Lymphoma.

Dong Hwan Kim, MD, Jin Tae Jung, MD, Eun Kyung Kwak, MD, Young Rok Do, MD, Jong Gwang Kim, MD, Tae In Park, MD, Sang Kyun Sohn, MD, Ki Wyong Kwon, MD, Hong Suk Song, MD, Kyu Bo Lee, MD

Blood (2004) 104 (11): 4548.

https://doi.org/10.1182/blood.V104.11.4548.4548

Published: 2004

NARROW

Relapsed Marginal Zone B-Cell Lymphoma: Clinical Features and Treatment Outcome.

Clinical Significance of Autoantibody Expression in Allogeneic Stem Cell Recipients.

Comparing Standard IPI with Revised-IPI in Patients with Diffuse Large B-Cell Lymphoma: Which Has a More Differential Potential for Predicting the Outcomes after R-CHOP Chemotherapy.

Clinical Efficacy of VEL-CTD (Bortezomib, Cyclophosphamide, Thalidomide, and Dexamethasone) Regimen in Patients with Relapsed or Refractory Multiple Myeloma: A Phase II Study

Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.

The Mobilization Effects of G-CSF, GM-CSF and Darbepoetin-α for Allogeneic Peripheral Blood Stem Cell Transplantation.

Early Onset of Acute Graft-Versus-Host Disease Indicating a Worse Prognosis in Terms of Chronic Graft-Versus-Host Disease and Survival Compared to Late Onset.

Risk Factors for Predicting CMV Infection in Allogeneic-PBSCT Setting: MNC Dose, Campath Use, and Acute GVHD Grade ≥II.

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Treatment Outcomes for Imatinib Mesylate and Allogeneic Stem Cell Transplantation in Patients with CML Based on RQ-PCR, and the Efficacy of Dose Escalation of Imatinib Mesylate in Patients with Cytogenetic or Hematologic Resistance.

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma

Multidrug Resistance-1 Gene Polymorphism Associated with the Outcomes after Allogeneic HLA-Identical Stem Cell Transplantation.

Rapid Helper T-Cell Recovery at 3 Months Correlates to Successful Transplant Outcomes after Allogeneic Stem Cell Transplantation.

Time to First Acute Exacerbation Can Stratify the Patients According to Their Prognosis during Clinical Course of Chronic GVHD: Evaluation of New End-Point for Chronic GVHD.

Survival Benefit of Asymptomatic Cytomegalovirus Reactivation and Early Lymphocyte Recovery after HLA-Identical Allogeneic Peripheral Blood Stem Cell Transplantation.

Risk Factor Analysis for Predicting Chronic Graft-Versus-Host Disease of Progressive or Quiescent Type in a Cohort of Patients with a History of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Transplantation with Higher Dose of Natural Killer Cells Associated with Better Outcomes in Terms of Non-Relapse Mortality and Infectious Events after Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Matched Sibling Donors.

IL-10 Promoter Gene Polymorphism Associated with the Occurrence of Chronic GVHD and Its Clinical Course during Systemic Immunosuppressive Treatment for Chronic GVHD after Allogeneic Peripheral Blood Stem Cell Transplantation.

Bcl-2 Mediated Apoptosis Interacts with p53-Dependent Pathway in Progression of Peripheral T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only